Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias

The outcomes of patients presenting with acute myocarditis and life‐threatening ventricular arrhythmias (LT‐VA) are unclear. The aim of this study was to assess the incidence and predictors of recurrent major arrhythmic events (MAEs) after hospital discharge in this patient population.

[1]  É. Marijon,et al.  Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  S. Rizzo,et al.  Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis. , 2020, Journal of the American College of Cardiology.

[3]  F. Crea,et al.  Long-Term Arrhythmic Risk Assessment in Biopsy-Proven Myocarditis. , 2020, JACC. Clinical electrophysiology.

[4]  S. Rizzo,et al.  Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. , 2020, Journal of the American College of Cardiology.

[5]  C. Basso,et al.  Programmed ventricular stimulation in patients with active vs previous arrhythmic myocarditis , 2020, Journal of cardiovascular electrophysiology.

[6]  L. Potena,et al.  Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction. , 2019, Journal of the American College of Cardiology.

[7]  S. Rizzo,et al.  Arrhythmias in myocarditis: State of the art. , 2019, Heart rhythm.

[8]  S. Rizzo,et al.  Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis. , 2019, International journal of cardiology.

[9]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[10]  L. Cooper,et al.  Management and outcomes of cardiac sarcoidosis: a 20‐year experience in two tertiary care centres , 2018, European journal of heart failure.

[11]  C. Giannattasio,et al.  Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry , 2018, Circulation.

[12]  G. Pontone,et al.  Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study. , 2017, Journal of the American College of Cardiology.

[13]  M. Kattan,et al.  Nomogram for survival analysis in the presence of competing risks. , 2017, Annals of translational medicine.

[14]  S. Ghio,et al.  Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis , 2017, Circulation.

[15]  R. Kolamunnage-Dona,et al.  Time-dependent ROC curve analysis in medical research: current methods and applications , 2017, BMC Medical Research Methodology.

[16]  C. Giannattasio,et al.  Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis. , 2017, International journal of cardiology.

[17]  K. Salmenkivi,et al.  Incidence, Risk Factors, and Outcome of Life-Threatening Ventricular Arrhythmias in Giant Cell Myocarditis , 2016, Circulation. Arrhythmia and electrophysiology.

[18]  K. Salmenkivi,et al.  Long‐term outcome and its predictors in giant cell myocarditis , 2016, European journal of heart failure.

[19]  J. Bartunek,et al.  Myocarditis in Clinical Practice. , 2016, Mayo Clinic proceedings.

[20]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[21]  G. Sinagra,et al.  Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias. , 2016, International journal of cardiology.

[22]  C. Held,et al.  Magnitude of Troponin Elevation and Long-Term Clinical Outcomes in Acute Coronary Syndrome Patients Treated With and Without Revascularization , 2015, Circulation. Cardiovascular interventions.

[23]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[24]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[25]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[26]  H. Figulla,et al.  Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction , 2010, Clinical Research in Cardiology.

[27]  J. Goeman.  L1 Penalized Estimation in the Cox Proportional Hazards Model , 2009, Biometrical journal. Biometrische Zeitschrift.

[28]  Andrea Mazzanti,et al.  [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.

[29]  Fredric Ginsberg,et al.  Fulminant myocarditis. , 2013, Critical care clinics.

[30]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .